Results 11 to 20 of about 262,464 (143)

A preliminary experience of plasma exchange in liver failure

Asian Journal of Transfusion Science, 2022
INTRODUCTION: Plasma exchange (PLEX) is one of the experimental modalities of treatment for liver failure. We report our experience of PLEX in patients with acute-(ALF) or acute-on-chronic (ACLF) liver failure.
Himanshu Dandu, Vivek Kumar, Amit Goel, Dheeraj Khetan, Tulika Chandra, Vipin Raj Bharti   +5 more
doaj   +1 more source

Acute-on-Chronic Liver Failure in Cirrhosis [PDF]

Journal of Clinical Medicine, 2021
Acute-on-chronic liver failure (ACLF) is a syndrome that develops in patients with acutely decompensated chronic liver disease. It is characterised by high 28-day mortality, the presence of one or more organ failures (OFs) and a variable but severe grade of systemic inflammation.
Gambino C., Piano S., Angeli P.
openaire   +2 more sources

Neutrophilia is more predictive than increased white blood cell counts for short-term mortality after liver transplantation in patients with acute-on-chronic liver failure [PDF]

Anesthesia and Pain Medicine, 2023
Background Acute-on-chronic liver failure (ACLF) is a life-threatening disease that requires urgent liver transplantation (LT). Accurate identification of high-risk patients is essential for predicting post-LT survival.
Kyoung-Sun Kim, Jae-Hwan Kim, Hye-Mee Kwon, Young-Jin Moon, Won-Jung Shin, Sung-Hoon Kim, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang   +8 more
doaj   +1 more source

Acute‐on‐chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population

JGH Open, 2022
Background and Aim Acute‐on‐chronic liver failure (ACLF) leads to multi‐organ failure related to high mortality rates. This study aimed to gather epidemiological data and validate a scoring system to predict mortality in ACLF.
Sakkarin Chirapongsathorn, Tongluk Teerasarntipan, Krit Tipchaichatta, Tanita Suttichaimongkol, Naichaya Chamroonkul, Chalermrat Bunchorntavakul, Sith Siramolpiwat, Siwaporn Chainuvati, Abhasnee Sobhonslidsuk, Apinya Leerapun, Teerha Piratvisuth, Wattana Sukeepaisarnjaroen, Tawesak Tanwandee, Sombat Treeprasertsuk   +13 more
doaj   +1 more source

Potentially hepatotoxic drugs are still being prescribed to liver disease patients under tertiary care: it is time to say enough

Revista Peruana de Investigación en Salud, 2021
Introduction and aim: Drug-induced liver injury (DILI) manifests as a spectrum of clinical presentations that carries morbidity and mortality. Patients with chronic liver disease (CLD), particularly hospitalized, are at high risk for developing DILI.
Rodrigo Dorelo, Samantha T.A. Barcelos, Magela Barros, Valeria Elustondo, Ysela Y.P. Pérez, Martin Oricchio, Nelson D.S. Uribe, Nelia Hernandez, Dvora Joveleviths, Mario R. Alvares-da-Silva   +9 more
doaj   +1 more source

Liver Support System and Transplant-Free Survival Patients with Liver Failure: An Evidence-Based Case Report

The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2022
Background: The mortality rate in patients with acute liver failure (ALF) and acute on chronic liver failure (ACLF) is still very high. Currently, liver support systems are an alternative therapy in bridging liver transplantation.
Aravinda Pravita, Kresna Adhiatma, Juferdy Kurniawan   +2 more
doaj   +1 more source

P-11 POTENTIALLY HEPATOTOXIC DRUGS ARE STILL BEING PRESCRIBED TO LIVER DISEASE PATIENTS UNDER TERTIARY CARE: IT IS TIME TO SAY ENOUGH

Annals of Hepatology, 2021
Introduction and Aim: Drug-induced liver injury (DILI) manifests as a spectrum of clinical presentations that carries morbidity and mortality. Patients with chronic liver disease (CLD), particularly hospitalized, are at high risk for developing DILI.
Rodrigo Dorelo, Samantha T.A. Barcelos, Magela Barros, Valeria Elustondo, Ysela Y.P. Pérez, Martin Oricchio, Nelson D.S. Uribe, Nelia Hernandez, Dvora Joveleviths, Mário R. Álvares-da-Silva   +9 more
doaj   +1 more source

Acute-On-Chronic Liver Failure [PDF]

Clinics in Liver Disease, 2014
The Model for End-Stage Liver Disease (MELD) has been the single best predictor of outcome of the progression of cirrhosis. Acute-on-chronic liver failure (ACLF) has been proposed as an alternative path in the natural history of cirrhosis. ACLF occurs in patients with chronic liver disease and is characterized by a precipitating event, resulting in ...
Sumeet K, Asrani, Jacqueline G, O'Leary
openaire   +2 more sources

Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare

Viruses, 2023
The hepatitis C virus (HCV) causes acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma, as well as extrahepatic manifestations such as malignant lymphoma. Currently, direct-acting antiviral agents (DAAs) against HCV infection can lead to
Tatsuo Kanda, Naoki Matsumoto, Tomotaka Ishii, Shuhei Arima, Shinji Shibuya, Masayuki Honda, Reina Sasaki-Tanaka, Ryota Masuzaki, Shini Kanezawa, Tsukasa Nishizawa, Yasuhiro Gon, Masahiro Ogawa, Hirofumi Kogure   +12 more
doaj   +1 more source

Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure

JHEP Reports, 2021
Background & Aims: Acute-on-chronic liver failure (ACLF) is usually associated with a precipitating event and results in the failure of other organ systems and high short-term mortality. Current prediction models fail to adequately estimate prognosis
Ben F.J. Goudsmit, Andries E. Braat, Maarten E. Tushuizen, Minneke J. Coenraad, Serge Vogelaar, Ian P.J. Alwayn, Bart van Hoek, Hein Putter   +7 more
doaj   +1 more source